Ph3 Study of SOC Chemo + Bevacizumab with or without INCA33890 1L mCC
Phase
Phase III Clinical Trial
Condition(s)
Colon Cancer, Rectal Cancer
Trial Number
07284849
Trial Status
OPEN
Study Overview
INCA033890-303: A Randomized Double-Blind Phase 3 Study of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
